SOUTH SAN FRANCISCO, Calif. —  Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura., “Astellas”), by which Astellas will license a suite of Twist’s VHH antibody libraries to be […]

Rigaku is pleased to announce the sale of another XtaLAB Synergy-ED electron diffractometer. The system will be installed at the Department of Chemistry at the University of Copenhagen in a new electron diffraction facility due to open in Autumn 2023. The Rigaku XtaLAB Synergy-ED is the world’s first turnkey electron diffractometer. Developed in collaboration with […]

SOPHiA GENETICS  supports The University of Maryland Medical Center to advance their rare disease research BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that the University of Maryland Medical Center (UMMC) is using SOPHiA GENETICS technology to enhance […]

SOPHiA DDM™ for Hereditary Cancers  Enables Krsnaa Diagnostics to Expand its NGS Offerings BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Krsnaa Diagnostics, India’s largest diagnostic services provider in radiology and pathology, is live on SOPHiA DDM™ technology. […]

SAN DIEGO, CA – Todaro Robotics, Inc, a leading laboratory automation and robotics company based in San Diego, has achieved a major milestone with its flagship client Abwiz Bio, Inc a company that speeds up the development of high impact monoclonal antibodies with its proprietary phage display technology.The milestone of operating continuously a very complex […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced it that it has reached a significant milestone with more than 1,000 Ella™ automated immunoassay instruments now in the field. The achievement is a testament to the growing demand across scientific and clinical research sectors for a fast and efficient immunoassay solution capable of delivering precise, and reliable biomarker analysis. Manufactured under […]

OPHiA DDM™ HRD Solution will help empower clinical researchers to advance cancer research   BOSTON and LAUSANNE, Switzerland  SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Tel Aviv Sourasky Medical Center (Ichilov), the largest acute care facility in Israel, has chosen to use […]

SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has already exceeded more than 200 orders for its revolutionary NovaSeq X sequencing system in the first quarter of 2023. The orders represent a diverse customer base spanning research and clinical customer segments in nearly 30 […]

HUNTSVILLE, Ala. —Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has announced that Discovery Genomics is the first commercial service laboratory in the world to receive two of the new NovaSeqTM X Plus Sequencing Systems from Illumina, Inc.  Discovery Genomics will expand its platform to five systems by the end of the year―positioning itself as […]

SOUTH PLAINFIELD, NEW JERSEY, USA — Admera Health, a leading provider of Next-Generation Sequencing services for researchers worldwide, has announced the acquisition of an Illumina NovaSeq X Plus sequencer to bolster its offering. The NovaSeq X Plus is a cutting-edge technology that enables high-throughput sequencing and supports a wide range of applications, including whole genome sequencing, transcriptome sequencing, targeted sequencing, […]